Login / Signup

Neuronal activity-induced, equilibrative nucleoside transporter-dependent, somatodendritic adenosine release revealed by a GRAB sensor.

Zhao-Fa WuYuting CuiHuan WangHao WuYi WanBohan LiLei WangSunlei PanWanling PengAo DongZhengwei YuanMiao JingMin XuMinmin LuoYu-Long Li
Published in: Proceedings of the National Academy of Sciences of the United States of America (2023)
The purinergic signaling molecule adenosine (Ado) modulates many physiological and pathological functions in the brain. However, the exact source of extracellular Ado remains controversial. Here, utilizing a newly optimized genetically encoded GPCR-Activation-Based Ado fluorescent sensor (GRAB Ado ), we discovered that the neuronal activity-induced extracellular Ado elevation is due to direct Ado release from somatodendritic compartments of neurons, rather than from the axonal terminals, in the hippocampus. Pharmacological and genetic manipulations reveal that the Ado release depends on equilibrative nucleoside transporters but not the conventional vesicular release mechanisms. Compared with the fast-vesicular glutamate release, the Ado release is slow (~40 s) and requires calcium influx through L-type calcium channels. Thus, this study reveals an activity-dependent second-to-minute local Ado release from the somatodendritic compartments of neurons, potentially serving modulatory functions as a retrograde signal.
Keyphrases
  • cerebral ischemia
  • oxidative stress
  • spinal cord
  • dna methylation
  • drug induced
  • gene expression
  • multiple sclerosis
  • brain injury
  • stress induced
  • prefrontal cortex